Jiang Li

Specialization: Hematologist/oncologist
Workplace: China, Guangzhou, Sun Yat-sen University Cancer Center (SYSUCC)
Jin Wang is a specialist at Sun Yat-sen University Cancer Center in Breast Oncology, where she is a Professor in the Department of Breast Oncology. She earned her M.D. from Peking Union Medical College in 2012 and worked as a surgeon at Sun Yat-sen University Cancer Center before completing a postdoctoral fellowship (2019–2020) in Surgical Oncology at Massachusetts General Hospital, Harvard University. Her research includes breast cancer surgery and reconstruction, with publications such as studies in Mol Cancer (2019) and Cancer Commun (2019).
Jin Wang is a specialist at Sun Yat-sen University Cancer Center, working as a Professor in Breast Oncology. She combines breast cancer treatment with surgical oncologic and reconstructive expertise, supported by an M.D. from Peking Union Medical College (2012) and a 2019–2020 postdoctoral fellowship in Surgical Oncology at Massachusetts General Hospital (Harvard University). Her research includes breast cancer surgery topics and outcomes.

How are we doing?

1 of 3

Information about this doctor is full and clear

Strongly disagree

Strongly agree

Qualifications

Jin Wang is a specialist at Sun Yat-sen University Cancer Center, where she serves as a Professor in the Department of Breast Oncology. Her clinical profile centers on breast oncology and breast cancer surgery, including breast cancer surgery and breast reconstruction surgery. She completed her M.D. at Peking Union Medical College in 2012 and then worked as a surgeon at Sun Yat-sen University Cancer Center. From 2019 to 2020, she completed a postdoctoral fellowship in the Department of Surgical Oncology at Massachusetts General Hospital, Harvard University. Her academic work includes publications related to triple-negative breast cancer and surgical staging questions, with listed papers such as “circKIF4A acts as a prognostic factor and mediator to regulate the progression of triple-negative breast cancer” (Mol Cancer, 2019) and “Is surgical axillary staging necessary…” (Cancer Commun, 2019). For international patients, the combination of reconstructive surgical focus and research-informed decision-making can be important when planning breast-conserving or staging strategies.

Education

2012 — Peking Union Medical College, M.D.

Work experience

2012-2019 — Surgeon, Sun Yat-sen University Cancer Center.
2019-2020 — Postdoctoral Fellow, Department of Surgical Oncology, Massachusetts General Hospital, Harvard University.
2019-present — Professor, Department of Breast Oncology, Sun Yat-sen University Cancer Center.

Clinical focus and techniques

At Sun Yat-sen University Cancer Center, Jin Wang’s breast oncology practice includes surgical oncologic and reconstructive care.

Breast cancer surgery.
Breast reconstruction surgery.

Professional societies and certifications

Memberships and certifications are not specified in the provided profile materials.

Academic output

2019 — Mol Cancer: circKIF4A in triple-negative breast cancer.
2019 — Cancer Commun: surgical axillary staging question in T1 breast cancer treated with breast-conserving therapy.
2021 — Eur J Surg Oncol: second invasive breast cancers after breast-conserving therapy.

Courses and advanced training

2019–2020 — Postdoctoral Fellowship, Department of Surgical Oncology, Massachusetts General Hospital, Harvard University.

Awards and recognition

Awards are not specified in the provided profile materials.

As a specialist at Sun Yat-sen University Cancer Center, Jin Wang supports international patients through breast oncology surgical planning and reconstruction. The profile materials do not specify spoken languages.